chlorpheniramine


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to chlorpheniramine: chlorpheniramine maleate

chlorpheniramine

 [klor″fen-ir´ah-mēn]
an antihistamine with sedative and anticholinergic effects; used orally or by injection as the maleate salt in the treatment of nasal, eye, and skin manifestations of allergic reactions, including allergic rhinitis, conjunctivitis, and itching, and orally as the maleate or tannate salt or polistirex complex as an ingredient in various cough and cold preparations.

chlorpheniramine

A first-generation alkylamine-type antihistamine (histamine H1 receptor antagonist) used to manage allergic rhinitis and urticaria. It is typically combined with decongestant in various proprietary formulations—e.g., Allerest, Contac, Tylenol Cold/Allergy.

chlorpheniramine

An antihistamine. See Allergy.

chlorpheniramine

Chlorphenamine, an antihistamine drug used for the symptomatic relief of allergic disorders such as hay fever and urticaria. The drug is on the WHO official list. Brand names are Piriton, and, with ephedrine, Haymine and Galpseud Plus.
References in periodicals archive ?
Chlorpheniramine or chlorphenamine (Figure 1A), commonly marketed in the form of chlorpheniramine maleate, is the first generationof alkylamine compounds for anti-histaminepurposes.
According to the company, the Hydrocodone Bitartrate and Chlorpheniramine Maleate Oral Solution combination medicine is indicated for relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older.
The E[C.sub.50] (effective concentration of histamine causing 50% of maximum response) obtained in the presence of essential oil, extracts, and chlorpheniramine in all three sets of experiments were significantly higher than that of saline (P < 0.05 to p < 0.001).
Extended-release chlorpheniramine maleate has been popular over the years as a fast-acting, first-generation allergy treatment--often compared with Benadryl in the national brand advertisements--as faster-acting, longer-lasting and less sleep-inducing than competing products, according to KVK Tech national account manager Lori Pinkleton.
14 June 2011 - US Cypress Pharmaceutical Inc said on Monday the US Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for ZUTRIPRO (hydrocodone bitartrate, chlorpheniramine maleate and pseudoephedrine HCl) Oral Solution (CIII) and REZIRA (hydrocodone bitartrate and pseudoephedrine HCl) Oral Solution (CIII).
Specialist pharmaceutical company Par Pharmaceutical Companies Inc (NYSE:PRX ) declared on Tuesday the receipt of final approval from the US Food and Drug Administration (FDA) for the company's Abbreviated New Drug Application for hydrocodone polistirex and chlorpheniramine polistirex (CIII) extended-release (ER) oral suspension (10 mg of hydrocodone bitartrate and 8 mg of chlorpheniramine maleate per 5 mL).
7 October 2010 - US Par Pharmaceutical Companies Inc (NYSE: PRX) said Tuesday that its licensing partner, Tris Pharma Inc, has received final approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for hydrocodone polistirex and chlorpheniramine polistirex (CIII) extended-release (ER) oral suspension (equivalent to 10 mg of hydrocodone bitartrate and 8 mg of chlorpheniramine maleate per 5 mL).